With this hypothesis, our goals were (i) to investigate whether the NAT2 gene polymorphisms are related to development of psoriasis vulgaris (ii) and to detect whether the NAT2 gene polymorphisms have an impact on the clinical features of psoriasis vulgaris such as age of onset and severity. Here, NAT2 is linked to psoriasis vulgaris.